# OnCo record nct00567580 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct00567580/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct00567580", "NCT00567580" ;
  schema:name "Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer"@en ;
  schema:alternateName "SPPORT"@en, "NRG Oncology RTOG 0534"@en ;
  schema:description "A phase 3 trial of Flutamide, Bicalutamide, Goserelin / leuprolide, Buserelin and Triptorelin in Prostate cancer, run by Radiation Therapy Oncology Group, with a status the registry has not verified recently."@en ;
  schema:url <https://onco.cc/trials/nct00567580/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00567580>, <https://doi.org/10.1016/S0140-6736(21)01790-6> ;
  onco:status "positive" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2008-02" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-bcr/> ;
  onco:drugs <https://onco.cc/drugs/flutamide/>, <https://onco.cc/drugs/bicalutamide/>, <https://onco.cc/drugs/goserelin/>, <https://onco.cc/drugs/buserelin/>, <https://onco.cc/drugs/triptorelin/> ;
  onco:companies <https://onco.cc/companies/nrg-oncology/> ;
  onco:trials <https://onco.cc/trials/getug-afu-16/>, <https://onco.cc/trials/radicals-hd/>, <https://onco.cc/trials/rtog-9601/> .